Cargando…
A Placebo Controlled Trial on Add-on Modafinil on the Anti-psychotic Treatment Emergent Hyperglycemia and Hyperlipidemia
Modafinil is non stimulant drug which is marketed for mainly Narcolepsy and daytime drowsiness. The clinical experience and Summary of Product Characteristics (SPC) of the drug also mentions Anorexia as one of the side effects. Anorexia can have a direct impact on the carbohydrate and fat intake, wh...
Autores principales: | Prasuna, Pathapati Lakshmi, Vijay Sagar, Kommu John, Sudhakar, Thatikonda Padma, Rao, Gundugurthi Prasada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031584/ https://www.ncbi.nlm.nih.gov/pubmed/24860217 http://dx.doi.org/10.4103/0253-7176.130982 |
Ejemplares similares
-
Impact of Modafinil Add-on with Atypical Anti-psychotics on Excessive Daytime Drowsiness
por: Prasuna, P Lakshmi, et al.
Publicado: (2015) -
Sexual Dysfunction in Women with Nonpsychotic Disorders: A
Cross-sectional Hospital-based Study
por: Thatikonda, Navya Spurthi, et al.
Publicado: (2022) -
Spirituality in Psychiatry Practice
por: Thatikonda, Padma Sudhakar
Publicado: (2019) -
Modafinil-induced Fixed Drug Eruption
por: Gaikwad, Girish Vasant, et al.
Publicado: (2012) -
Oxidative status of erythrocytes, hyperglycemia, and hyperlipidemia in diabetic cats
por: Zini, Eric, et al.
Publicado: (2020)